These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8413781)

  • 1. The apparent "epidemic" increase in the incidence of renal failure from diabetic nephropathy.
    Geberth S; Lippert J; Ritz E
    Nephron; 1993; 65(1):160. PubMed ID: 8413781
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic nephropathy: what are the diabetologist's expectations?
    Passa P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():6. PubMed ID: 10922967
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic nephropathy: a global and growing threat.
    Tang SC
    Hong Kong Med J; 2010 Aug; 16(4):244-5. PubMed ID: 20683064
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic nephropathy as a cause of terminal kidney failure in Poland].
    Rutkowski B
    Pol Arch Med Wewn; 1999; 102 Spec No():69-70. PubMed ID: 10916628
    [No Abstract]   [Full Text] [Related]  

  • 5. The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria.
    Alebiosu CO; Ayodele OE
    Trop Doct; 2006 Oct; 36(4):218-9. PubMed ID: 17034695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy and renal protective agents.
    Marchiando R; Elston MP
    S D J Med; 1999 Oct; 52(10):385-6. PubMed ID: 10546516
    [No Abstract]   [Full Text] [Related]  

  • 7. The rising tide of diabetic nephropathy--the warning before the flood?
    Raine AE
    Nephrol Dial Transplant; 1995; 10(4):460-1. PubMed ID: 7623987
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic nephropathy.
    Bloomgarden ZT
    Diabetes Care; 2008 Apr; 31(4):823-7. PubMed ID: 18375432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence and clinical characteristics of renal insufficiency in diabetic patients].
    Schwenger V; Müssig C; Hergesell O; Zeier M; Ritz E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1322-6. PubMed ID: 11719856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy. Is a pound of treatment better than an ounce of prevention?
    Goldstein DE
    Mo Med; 1994 Jun; 91(6):291. PubMed ID: 8052219
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic nephropathy in hemodialysis patients in Constantine, Algeria.
    Bouhabel A; Saadi N; Bendjeddou J; Laib Z; Hannache K; Aberkane A
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):139-40. PubMed ID: 25579737
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing chronic renal failure in diabetes.
    Anderson PW
    Am Fam Physician; 1995 Nov; 52(6):1660, 1662. PubMed ID: 7484673
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic nephropathy.
    Afifi M
    East Mediterr Health J; 2006 Sep; 12(5):703-4; author reply 704-5. PubMed ID: 17333814
    [No Abstract]   [Full Text] [Related]  

  • 15. The patient with diabetic nephropathy in the hospital.
    Thanasa G; Afthentopoulos IE
    EDTNA ERCA J; 1999; 25(4):28-31. PubMed ID: 10827596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
    Palmer AJ; Annemans L; Roze S; Lamotte M; Rodby RA; Ritz E
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):13-8. PubMed ID: 14703575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy: a nephrological point of view.
    Chanard J
    Diabetes Metab; 2000 Jul; 26 Suppl 4():4-5. PubMed ID: 10922966
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk factors in the development and progression of end-stage renal failure, the 21st century epidemic].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(1):9-15. PubMed ID: 11344969
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in progression of chronic renal failure.
    Striker GE; Klahr S
    Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.